SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Lou Gehrig — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientLou Gehrig
Date of birth1903-06-19
IdentifiersMRN HR-ET018-SYN-TD; SSN (made up) 000-18-6620
Document date1939-05-18
AuthorGavin Hollister, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Neuromuscular consultation with EMG and nerve conduction studies, and results of the MRI and blood tests. [S]

History of Present Illness

Mr. Gehrig returns two weeks after his first visit and is seen the same day by Dr. Nakamura of neuromuscular neurology, who performed EMG and nerve conduction studies this morning. The MRI of the brain and cervical spine a week ago was normal. Since the first visit he has had no new symptoms but feels his grip is a little weaker; he has kept to walking and stretching and has not played or lifted. He has no trouble speaking, swallowing or breathing. He asked to hear the results himself first, and plainly. [S]

ElementDetail
TestsEMG and nerve conduction studies this morning; MRI of the brain and cervical spine a week ago
SymptomsGrip slightly weaker; cramps; no speech, swallowing or breathing symptoms
ActivityNot playing or lifting; walking and stretching
His requestResults to him first, plainly

Review of Systems

SystemResultFinding
NeurologicalPositiveHand and left ankle weakness; cramps and twitching; no numbness
Ears, nose, mouth, and throatNegativeNo slurred speech, choking or drooling
RespiratoryNegativeNo breathlessness, including lying flat; no morning headaches
PsychiatricPositiveWorried and sleeping less while waiting for results; no thoughts of self-harm

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Riluzole 50 mg oral tablet, one tablet by mouth twice daily, an hour before or two hours after mealsOne tablet by mouth every 12 hours on an empty stomachOral route1939-05-18activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1939-05-18Body height183cmS
1939-05-18Body weight89.2kgS
1939-05-18Body mass index (BMI) [Ratio]26.6kg/m2S
1939-05-18Systolic blood pressure122mm[Hg]S
1939-05-18Diastolic blood pressure76mm[Hg]S
1939-05-18Heart rate70/minS
1939-05-18Respiratory rate14/minS
1939-05-18Body temperature36.6CelS
1939-05-18Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1939-05-18Forced vital capacity [Volume] Respiratory system4.52L>=4.1 LNormalS
1939-05-18FVC measured/predicted88%80% of predicted or more is normal; noninvasive ventilation is considered below 50%NormalS
1939-05-18Total score [ALSFRS-R]42{score}S
1939-05-18Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]7{score}S

Physical Exam

Vital signs recorded on 1939-05-18; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 122/76, pulse 70; weight 89.2 kg
NeurologicalExamined with Dr. Nakamura: wasting of the first dorsal interosseous and thenar muscles, left more than right; fasciculations in both arms, thighs and calves; grip and finger abduction 4/5 on the right and 4-/5 on the left; left ankle dorsiflexion 4-/5; reflexes brisk with spread, Hoffmann sign present on both sides, left plantar extensor; jaw jerk normal; tongue normal; sensation normal
RespiratoryNo accessory muscle use; normal chest expansion

Problems

ProblemClinical statusVerificationCodeProvenance
Progressive weakness and loss of coordination for about a year: fumbling with buttons and a bat, tripping on curbs, a fall on the ice in the winter, muscle cramps and twitching in the arms and thighs; no numbness, pain, double vision, or trouble speaking or swallowing. Examination: wasting of the hand muscles (left more than right), fasciculations in both arms and thighs, weakness of grip and of left ankle dorsiflexion, brisk reflexes with spread and a positive Hoffmann sign, normal sensation. Mixed upper and lower motor neuron signs; evaluation for motor neuron disease and its mimics begun, with neuromuscular neurology consultation bookedresolvedconfirmed M62.81S — Synthetic presenting problem anchored to his documented decline in 1938 and 1939; superseded by the diagnosis.
Amyotrophic lateral sclerosis, limb onset: progressive weakness for about a year with upper and lower motor neuron signs in the cervical and lumbosacral regions, and active and chronic denervation on EMG in the cervical, thoracic and lumbosacral regions with normal sensory nerve conduction; MRI of the brain and cervical spine and blood tests exclude mimics. Meets the Gold Coast criteria and the revised El Escorial category of clinically probable ALS. ALSFRS-R 42 and FVC 88% of predicted at diagnosis. Synthetic modern episode linked to his documented diagnosisactiveconfirmed G12.21S — Synthetic modern diagnosis; the documented 1939 diagnosis is the anchor. EMG findings, scores and timing are synthetic.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationUpper and lower motor neuron examination by regionAt diagnosis, then every visitCompleted todayUpper and lower motor neuron signs in the cervical and lumbosacral regions; bulbar region normal
ImagingEMG and nerve conduction studiesAt diagnosisCompleted todayActive and chronic denervation in three regions; normal sensory conduction; no conduction block
ImagingMRI of the brain and cervical spineAt diagnosis, to exclude mimicsCompleted todayNormal; no cord compression
LaboratoryBlood tests to exclude mimicsAt diagnosisCompleted todayCalcium, B12, TSH, A1c normal at intake; no monoclonal protein; HIV negative; creatine kinase 412 U/L
SurveyALSFRS-REvery 2 to 3 months in the multidisciplinary ALS clinicCompleted today42 of 48 at diagnosis
ImagingSeated forced vital capacityEvery 2 to 3 months in the multidisciplinary ALS clinicCompleted today4.52 L, 88% of predicted
ExaminationMaximal inspiratory pressure; supine capacity and overnight oximetry when values fall or symptoms appearEvery 2 to 3 months in the multidisciplinary ALS clinicCompleted todayMaximal inspiratory pressure -86 cmH2O; no orthopnea
ExaminationWeight and BMI (gastrostomy discussion if weight falls 5 to 10% or swallowing is unsafe; place while FVC is above 50%)Every visitCompleted today89.2 kg, BMI 26.6
ExaminationSpeech and swallowing assessmentEvery 2 to 3 months in the multidisciplinary ALS clinicCompleted todaySpeech and swallowing normal
SurveyCognitive and behavioral screeningAt diagnosis and periodicallyCompleted todayBrief cognitive screen normal; no behavioral change reported by him
SurveyDepression (PHQ-9)Every visitCompleted todayPHQ-9 7, mild; no thoughts of self-harm
LaboratoryALT on riluzoleMonthly for 3 months, then every 3 monthsDueBaseline ALT 32 U/L at intake; riluzole starts today
LaboratoryGenetic testing (SOD1 result decides tofersen)Offer at diagnosis to every person with ALSOrderedPanel sent today after genetic counseling
ReferralNeuromuscular neurology and multidisciplinary ALS clinicAt diagnosis, then every 2 to 3 monthsCompleted todaySeen by Dr. Nakamura today; clinic enrolment
Self-managementAdvance care planningEarly, then at each changeDueIntroduced today; to be held when he is ready

Goal progress:

Guideline basis: Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review) (2009); Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review) (2009); A proposal for new diagnostic criteria for ALS (Gold Coast criteria) (2020); El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis (2000); Evidence-based consensus guidelines for ALS genetic testing and counseling (2023)

Follow-up: Genetic counseling follow-up when the result returns. First full ALS clinic visit in about five weeks, with primary care the following week. Next scheduled visit 1939-06-29: six weeks after diagnosis: riluzole safety, genetic test result, multidisciplinary ALS clinic, mobility, mood, and his decision about work. [S]